The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
Open accessAbstract
Type I and III interferons (IFNs) activate similar downstream signaling cascades but unlike type I IFNs, type III IFNs (IFNλ) do not elicit strong inflammatory responses in vivo. Here we examined the molecular mechanisms underlying this disparity. Type I and III IFNs displayed kinetic differences in expression of IFN-stimulated genes and proinflammatory responses, with type I IFNs preferentially stimulating expression of the transcription factor IRF1. Type III IFNs failed to induce IRF1 expression due to low IFNλ receptor abundance and insufficient STAT1 activation on epithelial cells, and thus did not activate the IRF1 proinflammatory gene program. Rather, IFNλ stimulation preferentially induced factors implicated in tissue repair. Our findings suggest that IFN receptor compartmentalization and abundance confer a spatiotemporal division of labor wherein type III IFNs control viral spread at the site of the infection while restricting tissue damage; the transient induction of inflammatory responses by type I IFNs recruits immune effectors to promote protective immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Causal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,826
Honda, K., & Taniguchi, T. (2006) · Nature Reviews Immunology · doi:10.1038/nri1900 · Cited by 1,676
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. A., & Lemke, G. (2007) · Cell · doi:10.1016/j.cell.2007.10.034 · Cited by 1,055
CXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,001
The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.
Kang, C., Xu, Q., Martin, T. D., Li, M. Z., Demaria, M., Aron, L., Lu, T., Yankner, B. A., Campisi, J., & Elledge, S. J. (2015) · Science · doi:10.1126/science.aaa5612 · Cited by 982
Prokunina-Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R. M., Park, H., Dickensheets, H., Hergott, D., Porter-Gill, P., Mumy, A., Kohaar, I., et al. (2013) · Nature Genetics · doi:10.1038/ng.2521 · Cited by 928
Morita, M., Gravel, S.-P., Chénard, V., Sikström, K., Zheng, L., Alain, T., Gandin, V., Avizonis, D., Arguello, M., Zakaria, C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.001 · Cited by 842 · cited 1×
“Polysome analysis was performed as described previously (Morita et al., 2013).”
MethodMarcello, T., Grakoui, A., Barba–Spaeth, G., Machlin, E. S., Kotenko, S. V., Macdonald, M. R., & Rice, C. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.052 · Cited by 561
Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation
Zhang, X., Bogunovic, D., Payelle-Brogard, B., Francois-Newton, V., Speer, S. D., Yuan, C., Volpi, S., Li, Z., Sanal, O., Mansouri, D., et al. (2015) · Nature · doi:10.1038/nature13801 · Cited by 558
Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit
Nadjsombati, M. S., McGinty, J. W., Lyons-Cohen, M. R., Jaffe, J. B., DiPeso, L., Schneider, C., Miller, C. N., Pollack, J. L., Nagana Gowda, G. A., Fontana, M. F., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.016 · Cited by 556
Self-citationZhou, Z., Hamming, O. J., Ank, N., Paludan, S. R., Nielsen, A. L., & Hartmann, R. (2007) · Journal of Virology · doi:10.1128/jvi.02438-06 · Cited by 479
Galani, I. E., Triantafyllia, V., Eleminiadou, E.-E., Koltsida, O., Stavropoulos, A., Manioudaki, M., Thanos, D., Doyle, S. E., Kotenko, S. V., Thanopoulou, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.025 · Cited by 477
An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-Induced Antiviral Activity
Ank, N., Iversen, M. B., Bartholdy, C., Staeheli, P., Hartmann, R., Jensen, U. B., Dagnaes-Hansen, F., Thomsen, A. R., Chen, Z., Haugen, H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2474 · Cited by 419
Interferon-γ: A historical perspective
Billiau, A., & Matthys, P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.004 · Cited by 412
Hwang, S. Y., Hertzog, P. J., Holland, K. A., Sumarsono, S. H., Tymms, M. J., Hamilton, J. A., Whitty, G., Bertoncello, I., & Kola, I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11284 · Cited by 377
Pellegrini, S., John, J., Shearer, M., Kerr, I. M., & Stark, G. R. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.4605 · Cited by 374
Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity
Nice, T. J., Baldridge, M. T., McCune, B. T., Norman, J. M., Lazear, H. M., Artyomov, M., Diamond, M. S., & Virgin, H. W. (2015) · Science · doi:10.1126/science.1258100 · Cited by 345
Dumoutier, L., Tounsi, A., Michiels, T., Sommereyns, C., Kotenko, S. V., & Renauld, J.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404789200 · Cited by 291
Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection
Spurrell, J. C. L., Wiehler, S., Zaheer, R. S., Sanders, S. P., & Proud, D. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00397.2004 · Cited by 282
Role of STAT2 in the Alpha Interferon Signaling Pathway
Leung, S., Qureshi, S. A., Kerr, I. M., Darnell, J. E., & Stark, G. R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1312 · Cited by 279
Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In Vivo
Jewell, N. A., Cline, T., Mertz, S. E., Smirnov, S. V., Flaño, E., Schindler, C., Grieves, J. L., Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2010) · Journal of Virology · doi:10.1128/jvi.01703-09 · Cited by 263
The IRF Family Transcription Factors at the Interface of Innate and Adaptive Immune Responses
Ikushima, H., Negishi, H., & Taniguchi, T. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020321 · Cited by 262
McKendry, R., John, J., Flavell, D., Müller, M., Kerr, I. M., & Stark, G. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11455 · Cited by 262
Davidson, S., McCabe, T. M., Crotta, S., Gad, H. H., Hessel, E. M., Beinke, S., Hartmann, R., & Wack, A. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606413 · Cited by 240
Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier
Lazear, H. M., Daniels, B. P., Pinto, A. K., Huang, A. C., Vick, S. C., Doyle, S. E., Gale, M., Klein, R. S., & Diamond, M. S. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4304 · Cited by 234
Self-citationISG15 deficiency and increased viral resistance in humans but not mice
Speer, S. D., Li, Z., Buta, S., Payelle-Brogard, B., Qian, L., Vigant, F., Rubino, E., Gardner, T. J., Wedeking, T., Hermann, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms11496 · Cited by 206
Fredericksen, B. L., & Gale, M. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2913-2923.2006 · Cited by 194
Self-citationIL‐18 enhances IFN‐γ‐induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes
Kanda, N., Shimizu, T., Tada, Y., & Watanabe, S. (2007) · European Journal of Immunology · doi:10.1002/eji.200636420 · Cited by 169
Clarke, D. L., Clifford, R. L., Jindarat, S., Proud, D., Pang, L., Belvisi, M., & Knox, A. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.0999952 · Cited by 164
Baldridge, M. T., Lee, S., Brown, J. J., McAllister, N., Urbanek, K., Dermody, T. S., Nice, T. J., & Virgin, H. W. (2017) · Journal of Virology · doi:10.1128/jvi.02079-16 · Cited by 158
McFarland, A. P., Horner, S. M., Jarret, A. P., Joslyn, R. C., Bindewald, E., Shapiro, B. A., Delker, D. A., Hagedorn, C. H., Carrington, M. N., Gale, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2758 · Cited by 147
Self-citationInterferon Lambda Genetics and Biology in Regulation of Viral Control
Hemann, E. A., Gale, M., & Savan, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01707 · Cited by 137
Self-citationEmma, M. R., Iovanna, J., Bachvarov, D. R., Puleio, R., Loria, G. R., Augello, G., Candido, S., Libra, M., Gulino, A., Cancila, V., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.175 · Cited by 125
Deb, A., Haque, S. J., Mogensen, T. H., Silverman, R. H., & Williams, B. R. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6170 · Cited by 123
Jilg, N., Lin, W., Hong, J., Schaefer, E. A. K., Wolski, D., Meixong, J., Goto, K., Brisac, C., Chusri, P., Fusco, D. N., et al. (2013) · Hepatology · doi:10.1002/hep.26653 · Cited by 105
Chiriac, M. T., Buchen, B., Wandersee, A., Hundorfean, G., Günther, C., Bourjau, Y., Doyle, S. E., Frey, B., Ekici, A. B., Büttner, C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.015 · Cited by 105
Pervolaraki, K., Stanifer, M. L., Muenchau, S., Renn, L. A., Albrecht, D., Kurzhals, S. R., Senís, E., Grimm, D., Schröder–Braunstein, J., Rabin, R. L., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00459 · Cited by 96
SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)–induced gene expression in vivo
Blumer, T., Coto‐Llerena, M., Duong, F. H. T., & Heim, M. H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.788877 · Cited by 75
Interferon lambda 4 expression is suppressed by the host during viral infection
Hong, M., Schwerk, J., Lim, C., Kell, A. M., Jarret, A. P., Pangallo, J., Loo, Y., Liu, S., Hagedorn, C. H., Gale, M., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160437 · Cited by 68
Self-citationCuevas, R. A., Ghosh, A., Wallerath, C., Hornung, V., Coyne, C. B., & Sarkar, S. N. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501359 · Cited by 67
Self-citationThe Superiority of IFN-λ as a Therapeutic Candidate to Control Acute Influenza Viral Lung Infection
Kim, S.-J., Kim, M., Kim, C., Kang, J. W., Shin, H. K., Kim, D., Won, T., Han, D. H., Rhee, C., Yoon, J., et al. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0174oc · Cited by 58
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition
Enane, F. O., Shuen, T. W. H., Gu, X., Ebrahem, Q., Przychodzen, B. P., Makishima, H., Bodo, J., Ng, J., Chee, C. L., Ba, R., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93488 · Cited by 53
Bhushal, S., Wolfsmüller, M., Selvakumar, T. A., Kemper, L., Wirth, D., Hornef, M. W., Häuser, H., & Köster, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00671 · Cited by 49
Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling
Jarret, A. P., McFarland, A. P., Horner, S. M., Kell, A. M., Schwerk, J., Hong, M., Badil, S., Joslyn, R. C., Baker, D. P., Carrington, M. N., et al. (2016) · Nature Medicine · doi:10.1038/nm.4211 · Cited by 48
Self-citationLigand-independent pathway that controls stability of interferon alpha receptor
Liu, J., Plotnikov, A., Banerjee, A., Kumar, K. G., Ragimbeau, J., Marijanovic, Z., Baker, D. P., Pellegrini, S., & Fuchs, S. Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.137 · Cited by 47
Isolation of Newly Transcribed RNA Using the Metabolic Label 4-Thiouridine
Garibaldi, A., Carranza, F., & Hertel, K. J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7204-3_13 · Cited by 47
Rodríguez, J. L., Sandoval, J., Serviddio, G., Sastre, J., Morante, M., Perrelli, M.-G., Martínez‐Chantar, M. L., Viña, J., Vinã, J. R., Mato, J. M., et al. (2006) · Biochemical Journal · doi:10.1042/bj20060380 · Cited by 39
Simian Virus 40 Large T Antigen Induces IFN-Stimulated Genes through ATR Kinase
Forero, A., Giacobbi, N. S., McCormick, K. D., Gjoerup, O. V., Bakkenist, C. J., Pipas, J. M., & Sarkar, S. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303470 · Cited by 38
Self-citationRegulation of Interferon-Dependent mRNA Translation of Target Genes
Kroczyńska, B., Mehrotra, S., Arslan, A. D., Kaur, S., & Platanias, L. C. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0148 · Cited by 37
Forero, A., Tisoncik-Go, J., Watanabe, T., Zhong, G., Hatta, M., Tchitchek, N., Selinger, C., Chang, J., Barker, K., Morrison, J. M., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02974-15 · Cited by 36
Self-citationHepatitis C virus population dynamics in human lymphocytes and hepatocytes infected in vitro.
Kato, N., Shimotohno, K., Tanaka, T., Mizutani, T., Sugiyama, K., & Ikeda, M. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-8-1859 · Cited by 35
Schwerk, J., Köster, M., Häuser, H., Rohde, M., Fulde, M., Hornef, M. W., & May, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072700 · Cited by 31
Soini, T., Eloranta, K., Pihlajoki, M., Kyrönlahti, A., Akinrinade, O., Andersson, N., Lohi, J., Pakarinen, M. P., Wilson, D. B., & Heikinheimo, M. (2018) · Tumor Biology · doi:10.1177/1010428318785498 · Cited by 17
Cited by
Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909
A neutrophil response linked to tumor control in immunotherapy
Gungabeesoon, J., Gort-Freitas, N. A., Kiss, M., Bolli, E., Messemaker, M., Siwicki, M., Hicham, M., Bill, R., Koch, P., Cianciaruso, C., et al. (2023) · Cell · doi:10.1016/j.cell.2023.02.032 · Cited by 412
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Broggi, A., Ghosh, S., Sposito, B., Spreafico, R., Balzarini, F., Lo Cascio, A., Clementi, N., De Santis, M., Mancini, N., Granucci, F., et al. (2020) · Science · doi:10.1126/science.abc3545 · Cited by 402
Pathogenesis of pneumonia and acute lung injury
Long, M. E., Mallampalli, R. K., & Horowitz, J. C. (2022) · Clinical Science · doi:10.1042/cs20210879 · Cited by 390
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
Vanderheiden, A., Ralfs, P., Chirkova, T., Upadhyay, A. A., Zimmerman, M. G., Bedoya, S., Aoued, H., Tharp, G. M., Pellegrini, K. L., Manfredi, C., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00985-20 · Cited by 301
Metadata
- Authors
- Forero, A., Ozarkar, S., Li, H., Lee, C. H., Hemann, E. A., Nadjsombati, M. S., Hendricks, M. R., So, L., Green, R., Roy, C. N., Sarkar, S. N., von Moltke, J., Anderson, S. K., Gale, M., & Savan, R.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 51
- Issue
- 3
- Pages
- 451-464.e6
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2970141704
- Cited by
- 265
- References
- 63
- FWCI
- 9.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.